数据挖掘框架用于发现和聚类非典型糖尿病的表型
研究开发了DiscoverAD数据挖掘框架,在278名成年糖尿病患者中训练并在758名多民族1型糖尿病患儿中测试,用于识别和聚类非典型糖尿病表型。研究在CCHC队列中识别出11.5%的非典型糖尿病频率,在儿童注册队列中为5.3%,并分别聚类出4个和2个不同表型组。结论认为DiscoverAD可适配不同数据集以识别和定义非典型糖尿病表型。
要点
- DiscoverAD框架在CCHC成年糖尿病患者中识别非典型糖尿病频率为11.5%。
- 在TCHRNO-1儿童1型糖尿病注册队列中非典型糖尿病频率为5.3%。
- Study A聚类出4组非典型糖尿病表型,Study B聚类出2组不同表型。
核心结论
- DiscoverAD可适配不同数据集,基于可用临床变量识别和定义非典型糖尿病参与者的表型。
研究设计与样本
- 研究开发了DiscoverAD数据挖掘框架,在Cameron County Hispanic Cohort(CCHC)中278名成年糖尿病患者(Study A)的手工分类非典型糖尿病特征上进行训练。
- 随后在Texas Children's Hospital Registry for New-Onset Type 1 Diabetes(TCHRNO-1)中758名多民族1型糖尿病患儿(Study B)中测试DiscoverAD。
主要发现
- 在CCHC(Study A)中识别非典型糖尿病频率为11.5%,在儿童TCHRNO-1(Study B)中为5.3%。
- Study A聚类分析识别出4个不同的非典型糖尿病组:聚类1为65 kDa谷氨酸脱羧酶自身抗体(GAD65Ab)阳性、成年发病、病程长、β细胞功能保留、无胰岛素治疗;聚类2为GAD65Ab阴性、诊断年龄≤21岁;聚类3为GAD65Ab阴性、成年发病、β细胞功能差、缺乏中心性肥胖;聚类4为易发生糖尿病酮症酸中毒(DKA)但缺乏典型1型糖尿病表型的参与者。
- 将DiscoverAD应用于Study B的儿童1型糖尿病患者,发现2个不同的非典型糖尿病组:聚类1为自身抗体阴性、β细胞功能差、体质指数(BMI)较低;聚类2为自身抗体阳性、BMI较高、DKA发生率较高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Some individuals present with forms of diabetes that are "atypical" (AD), which do not conform to typical features of either type 1 diabetes (T1D) or type 2 diabetes (T2D). These forms of AD display a range of phenotypic characteristics that likely reflect different endotypes based on unique etiologies or pathogenic processes. OBJECTIVE: To develop an analytical approach to identify and cluster phenotypes of AD. METHODS: We developed Discover Atypical Diabetes (DiscoverAD), a data mining framework, to identify and cluster phenotypes of AD. DiscoverAD was trained against characteristics of manually classified patients with AD among 278 adults with diabetes within the Cameron County Hispanic Cohort (CCHC) (Study A). We then tested DiscoverAD in a separate population of 758 multiethnic children with T1D within the Texas Children's Hospital Registry for New-Onset Type 1 Diabetes (TCHRNO-1) (Study B). RESULTS: We identified an AD frequency of 11.5% in the CCHC (Study A) and 5.3% in the pediatric TCHRNO-1 (Study B). Cluster analysis identified 4 distinct groups of AD in Study A: cluster 1, positive for the 65 kDa glutamate decarboxylase autoantibody (GAD65Ab), adult-onset, long disease duration, preserved beta-cell function, no insulin treatment; cluster 2, GAD65Ab negative, diagnosed at age ≤21 years; cluster 3, GAD65Ab negative, adult-onset, poor beta-cell function, lacking central obesity; cluster 4, diabetic ketoacidosis (DKA)-prone participants lacking a typical T1D phenotype. Applying DiscoverAD to the pediatric patients with T1D in Study B revealed 2 distinct groups of AD: cluster 1, autoantibody negative, poor beta-cell function, lower body mass index (BMI); cluster 2, autoantibody positive, higher BMI, higher incidence of DKA. CONCLUSION: DiscoverAD can be adapted to different datasets to identify and define phenotypes of participants with AD based on available clinical variables.
引用
- Parikh HM, Remedios CL, Hampe CS, et al. Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes. J Clin Endocrinol Metab. 2023. PMID: 36314086. doi:10.1210/clinem/dgac632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。